Guardian Pharmacy Services, Inc.

Guardian Pharmacy Services, Inc. is a leading provider of long-term care (LTC) pharmacy services, offering technology-enabled solutions to residents within long-term health care facilities. Headquartered in Atlanta, Georgia, the company's mission is to deliver safe and reliable medication management, focusing on improving patient health outcomes and ensuring survey readiness through community-based pharmacy services.

The company provides a comprehensive suite of services including clinical support, drug dispensing, and administration capabilities tailored for residents in assisted living facilities (ALFs), behavioral health facilities (BHFs), group homes, and skilled nursing facilities (SNFs). Key offerings encompass customized dispensing, compliance packaging, electronic medication administration record (eMAR) integration, clinical pharmacist medication reviews, formulary coordination, caregiver training, and proprietary data analytics. Guardian Pharmacy Services operates through a network of local pharmacies supported by a national team, allowing for personalized care while leveraging centralized resources.

Guardian Pharmacy Services became publicly traded on the New York Stock Exchange (NYSE) under the ticker symbol GRDN in September 2024. The company is recognized as one of the nation's largest and fastest-growing long-term care pharmacy providers, positioning itself as a leading independent player behind institutional divisions of CVS Health and PharMerica. As of December 31, 2025, Guardian Pharmacy Services operated 61 pharmacies across 38 states, serving approximately 205,000 residents in about 8,400 LTC facilities. Fred Burke serves as the President and CEO, and is a co-founder of the company. The company has demonstrated consistent growth, reporting a 17.4% increase in revenue for the fourth quarter of 2025 and is scheduled to release its first-quarter 2026 results on May 6, 2026.